Projects per year
Personal profile
Other
Short Biography
David obtained his PhD in the field of molecular diagnostics of haematological malignancies in Salamanca, Spain. In 2004, he obtained a position at The Royal Marsden Hospital and The Institute of Cancer Research in London as a Clinical Scientist to lead the Molecular Diagnostics Laboratory. David has been involved in several translational research projects, particularly in the study of predictive and prognostics molecular biomarkers in haematological and solid tumours. He was one of the principal investigators on the CRUK stratified medicine programme, working in close collaboration with the pharmaceutical and biotech industry to deliver personalised medicine for cancer patients using genomics. In 2016 he was appointed Professor of Genomic Medicine at Queen’s University Belfast and leads the Genomics and Bioinformatics teams in the Precision Medicine Centre. His research is centred around developing and applying genomic stratification tools for precision medicine and to better classify and monitor disease.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where David Gonzalez de Castro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
R3005CNR: Establishing a Precision Medicine Catapult Centre of Excellence in Northern Ireland
Salto-Tellez, M. (PI), Gonzalez de Castro, D. (CoI), James, J. (CoI), Kennedy, R. (CoI), McArt, D. (CoI) & Waugh, D. (CoI)
01/12/2017 → …
Project: Research
-
R1131CNR: KaryoSequencing: a novel and comprehensive approach for clinical diagnosis of genomic aberrations in myeloid disorders
10/01/2020 → 30/06/2022
Project: Research
Research output
-
Comparison of results from two commercially available in-house tissue-based comprehensive genomic profiling solutions research-use only AVENIO tumor tissue comprehensive genomic profiling kit and TruSight oncology 500 Assay
Adams, H.-P., Hiemenz, M. C., Hertel, K., Fuhlbrück, F., Thomas, M., Oughton, J., Sorensen, H., Schlecht, U., Allen, J. M., Cantone, M., Osswald, S., Gonzalez, D., Pikarsky, E., De Vos, M., Schuuring, E. & Wieland, T., Nov 2024, In: Journal of Molecular Diagnostics. 26, 11, p. 1018-1033 16 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile26 Downloads (Pure) -
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
Khouja, M., Jiang, L., Pal, K., Stewart, P. J., Regmi, B., Schwarz, M., Klapper, W., Alig, S. K., Darzentas, N., Kluin-Nelemans, H. C., Hermine, O., Dreyling, M., Gonzalez de Castro, D., Hoster, E., Pott, C. & On behalf of the European Mantle Cell Lymphoma Network, 16 Sept 2024, (Early online date) In: Leukemia.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Initiation of molecular testing of endometrial carcinomas in a population‐based setting: practical considerations and pitfalls
Machuca‐Aguado, J., Catherwood, M., Houghton, O., Taylor, J., Shah, R., Ben‐Mussa, A., Gonzalez, D. & McCluggage, W. G., 28 Nov 2024, (Early online date) In: Histopathology.Research output: Contribution to journal › Article › peer-review
-
Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease
Alcoceba, M., Stewart, J. P., García‐Álvarez, M., Díaz, L. G., Jiménez, C., Medina, A., Chillón, M. C., Gazdova, J., Blanco, O., Díaz, F. J., Peñarrubia, M. J., Fernández, S., Montes, C., Cabero, A., Caballero, M. D., García‐Sanz, R., González, M., González, D., Tamayo, P. & Gutiérrez, N. C. & 2 others, , 29 May 2024, (Early online date) In: British Journal of Haematology.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)22 Downloads (Pure) -
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Larkin, J., Marais, R., Porta, N., Gonzalez de Castro, D., Parsons, L., Messiou, C., Stamp, G., Thompson, L., Edmonds, K., Sarker, S., Banerji, J., Lorigan, P., Evans, T. R. J., Corrie, P., Marshall, E., Middleton, M. R., Nathan, P., Nicholson, S., Ottensmeier, C. & Plummer, R. & 3 others, , 21 Mar 2024, In: Cell Reports Medicine. 5, 3, 16 p., 101435.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)18 Downloads (Pure)
-
Behnoush Abedi-Ardekani
Craig, S. (Host), James, J. (Host), Salto-Tellez, M. (Host), McCombe, K. (Host), Albraikat, M. (Host), Graham, L. (Host), Maxwell, P. (Host), Gonzalez de Castro, D. (Host) & Lewis, C. (Host)
14 Sept 2023 → 15 Sept 2023Activity: Hosting a visitor types › Hosting an academic visitor
-
Penny Wilson
James, J. (Host), Salto-Tellez, M. (Host) & Gonzalez de Castro, D. (Host)
14 Aug 2019Activity: Hosting a visitor types › Hosting of external, non-academic visitor
-
Nick Chism
James, J. (Host) & Gonzalez de Castro, D. (Host)
05 Jul 2019Activity: Hosting a visitor types › Hosting of external, non-academic visitor